¡Last updated 2019/7/16
EDeoxynucleotides
ERibonucleotides
@
@
@






20th Aniversary (July 15th, 2019)@


yBusiness Outlinez
We are engaged in R&D and commercialization of gene diagnostic agents, pharmaceutical materials,biosensors, and catalysts using DNA/RNA derivatives as materials based on nucleic acid chemistry technology through joint studies with research organizations, including universities.

yProducts & Servicesz

¡Products
ENucleotide for gene amplification
We have realized high-quality, low-price gnucleotides for gene amplificationh using our original phosphorylation technology.

EContract synthesis
In the gcontract synthesish business, we have a track record of producing special nucleic acid compounds, including special nucleosides, nucleotides, and oligonucleotides using our special technology.

¡Commercialization Strategy
EDrug Discovery
We are carrying out research and product development of Small molecules that target DNA/RNA.





Copyright(c) 2008@GeneACT,Inc. All Rihgts Reserved.